Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00785655Phase 3Completed
Phase 3, open-label, single-arm trial of lactic acid, sponsored by Sanofi. Primary endpoint: Primary and Accumulated Dermical Irritability and Dermical Sensitivity. Started Jul 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00785655.